ArticleAnnals of surgical oncology2026

Neoadjuvant Combination Therapy with Tyrosine Kinase and Immune Checkpoint Inhibitors in Anaplastic Thyroid Cancer: A Single-Center, Real-World Experience.

Yuntao Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.